Flavonoids as multi-target therapeutic agents: A systematic review of pharmacological evidence, molecular mechanisms, and clinical translation

Authors

  • Jahnabi Sarmah North East Practical Education Development Sanstha, Gandhinagar, Tetelia, Maloibari Road, Sonapur, Kamrup (Metro), Assam 782403
  • Dhiraj Bishya Faculty of Pharmaceutical Science, Assam down town University, Panikhaiti, Gandhinagar, Guwahati, Assam, India, 781026
  • Rosamund Jyrwa Pratiksha Institute of Pharmaceutical Sciences, Panikhaiti, Guwahati, Assam, India, 781026
  • Ikram Hussain Rahman Institute of Pharmaceutical Sciences and Research, Tepesia, Kamarkuchi, Sonapur, Kamrup (M), Assam, India

Keywords:

Flavonoids, Polyphenols, Multi-target therapy, Pharmacology, Drug discovery, Molecular targets, Precision medicine, Natural products, Network pharmacology, PRISMA

Abstract

Background: Flavonoids, the largest class of plant polyphenols, are increasingly recognized as multi-target therapeutic agents that can modulate diverse molecular pathways involved in chronic diseases. Unlike previous reviews focusing on individual flavonoid subclasses or specific diseases, this systematic review provides a comprehensive evaluation of their molecular mechanisms, pharmacokinetics, network pharmacology, and clinical applications. Methodology: We conducted a systematic review following the PRISMA 2020 guidelines. We searched electronic databases, including PubMed, Scopus, Web of Science, Embase, ScienceDirect, Cochrane Library, and Google Scholar, for studies published between January 2000 and March 2024. We assessed eligible in vitro, in vivo, and clinical studies using established risk-of-bias tools and evaluated evidence certainty using the GRADE framework. Results and Discussion: The review identified extensive preclinical evidence and an emerging body of clinical studies supporting flavonoids' therapeutic potential. These compounds modulate multiple molecular targets, including inflammatory mediators, kinase signaling pathways, transcription factors, and apoptotic regulators, across cancer, cardiovascular, metabolic, neurodegenerative, and inflammatory disorders. Clinical studies indicate modest but promising therapeutic benefits; however, poor oral bioavailability, rapid metabolism, and heterogeneity in study design and intervention protocols constrain broader clinical translation. Conclusion: Flavonoids demonstrate substantial multi-target therapeutic potential supported by robust mechanistic evidence and encouraging clinical findings. Nevertheless, well-designed, adequately powered clinical trials, standardized formulations, and advanced bioavailability-enhancing delivery systems are essential to establish their efficacy and facilitate widespread clinical application.

Downloads

Published

2026-11-15

How to Cite

Sarmah, J., Bishya, D., Jyrwa, R., & Hussain, I. (2026). Flavonoids as multi-target therapeutic agents: A systematic review of pharmacological evidence, molecular mechanisms, and clinical translation. Journal of Applied Pharmacognosy and Phytochemistry, 4(2), 1-16. Retrieved from https://joapponline.com/index.php/joapp/article/view/72

Issue

Section

Articles